HemaGel® is a hydrophilic gel developed to surface wound treatment and is the only such product based on the scientific patent of the Institute of Macromolecular Chemistry of the Academy of Sciences of the Czech Republic.
The uniqueness of this medical device is given by the patented structure of the hydrophilic gel with its inbuilt scavenger of free radicals- a structure not found in any other hydrogel wound dressings. Free oxygen radicals are present to a great extent in all types of trauma and they hamper the whole healing process. The joint effects of HemaGel and the moist wound healing method lead to a completely new approach to the treatment of wounds.
- Fundamental acceleration of the healing process
- Decreases pain
- Prevents wound desiccation
- Prevents the development of scars
Once HemaGel® is applied, an elastic layer forms immediately on the surface of the wound. This absorbs free oxygen radicals and eventually any secretions or fluids from the wound. At the same time, this layer prevents the formation of a scab and supplies a sufficient amount of moistness for so-called “moist” wound treatment. The molecular structure of HemaGel enables it to remain continuously active and at the same time prevents the penetration of any of its components into the organism. Thus, HemaGel is completely safe for all patients, including mothers and children.
HemaGel® has also won approval abroad. As one of the first products of non-American origin, it may use the seal of acceptance of the American Paediatric Medical Association (APMA), which in the USA associates over 16 000 physicians specialising in the correct treatment and care for feet.
Barcode: 8594177490471
